Roth Capital Has Bullish Outlook for MGRM FY2028 Earnings

Monogram Orthopaedics, Inc. (NASDAQ:MGRM) – Stock analysts at Roth Capital boosted their FY2028 earnings per share (EPS) estimates for Monogram Orthopaedics in a research report issued to clients and investors on Thursday, March 13th. Roth Capital analyst J. Wittes now forecasts that the company will earn $0.09 per share for the year, up from their prior forecast of $0.06. Roth Capital currently has a “Strong-Buy” rating on the stock. The consensus estimate for Monogram Orthopaedics’ current full-year earnings is ($0.49) per share. Roth Capital also issued estimates for Monogram Orthopaedics’ FY2029 earnings at $0.41 EPS.

Monogram Orthopaedics (NASDAQ:MGRM) last announced its earnings results on Wednesday, March 12th. The company reported ($0.08) EPS for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.03.

Separately, Roth Mkm assumed coverage on Monogram Orthopaedics in a report on Monday, December 9th. They issued a “buy” rating and a $4.00 price objective for the company.

Monogram Orthopaedics Stock Up 0.9 %

Shares of Monogram Orthopaedics stock opened at $2.33 on Friday. The business has a 50 day moving average of $2.54 and a 200 day moving average of $2.49. The company has a market cap of $79.95 million, a PE ratio of -4.96 and a beta of 1.66. Monogram Orthopaedics has a 52 week low of $1.53 and a 52 week high of $4.90.

Hedge Funds Weigh In On Monogram Orthopaedics

Institutional investors have recently added to or reduced their stakes in the company. Barclays PLC bought a new position in Monogram Orthopaedics in the third quarter worth $29,000. State Street Corp purchased a new stake in shares of Monogram Orthopaedics in the third quarter worth $62,000. Geode Capital Management LLC grew its stake in shares of Monogram Orthopaedics by 1,267.4% in the third quarter. Geode Capital Management LLC now owns 210,144 shares of the company’s stock worth $557,000 after acquiring an additional 194,776 shares during the last quarter. Jane Street Group LLC purchased a new stake in shares of Monogram Orthopaedics in the fourth quarter worth $25,000. Finally, Northern Trust Corp grew its stake in shares of Monogram Orthopaedics by 110.6% in the fourth quarter. Northern Trust Corp now owns 45,873 shares of the company’s stock worth $109,000 after acquiring an additional 24,088 shares during the last quarter. Institutional investors own 0.45% of the company’s stock.

About Monogram Orthopaedics

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.